YU40813B - Process for obtaining 1-tert-butylamino-3-(2,5 dichlorophenoxio-2-propanoe - Google Patents

Process for obtaining 1-tert-butylamino-3-(2,5 dichlorophenoxio-2-propanoe

Info

Publication number
YU40813B
YU40813B YU549/77A YU54977A YU40813B YU 40813 B YU40813 B YU 40813B YU 549/77 A YU549/77 A YU 549/77A YU 54977 A YU54977 A YU 54977A YU 40813 B YU40813 B YU 40813B
Authority
YU
Yugoslavia
Prior art keywords
dichlorophenoxio
propanoe
butylamino
tert
obtaining
Prior art date
Application number
YU549/77A
Other languages
English (en)
Other versions
YU54977A (en
Inventor
A Hajos
M Fekete
M Kurti
T Lang
L Toldy
J Borvendeg
L Nagy
S Flek
I Polgari
I Eekes
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of YU54977A publication Critical patent/YU54977A/xx
Publication of YU40813B publication Critical patent/YU40813B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
YU549/77A 1976-03-02 1977-03-01 Process for obtaining 1-tert-butylamino-3-(2,5 dichlorophenoxio-2-propanoe YU40813B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU76GO00001331A HU172137B (hu) 1976-03-02 1976-03-02 Sposob poluchenija zamehhjonnykh proizvodnykh fenoksi-propanolamina

Publications (2)

Publication Number Publication Date
YU54977A YU54977A (en) 1982-10-31
YU40813B true YU40813B (en) 1986-06-30

Family

ID=10996805

Family Applications (1)

Application Number Title Priority Date Filing Date
YU549/77A YU40813B (en) 1976-03-02 1977-03-01 Process for obtaining 1-tert-butylamino-3-(2,5 dichlorophenoxio-2-propanoe

Country Status (25)

Country Link
US (1) US4310549A (fr)
JP (1) JPS5923299B2 (fr)
AT (1) AT348507B (fr)
AU (1) AU508766B2 (fr)
BE (1) BE851938A (fr)
CA (1) CA1091254A (fr)
CH (1) CH627732A5 (fr)
CS (1) CS190340B2 (fr)
DD (1) DD128610A5 (fr)
DE (1) DE2709109C3 (fr)
DK (1) DK143554C (fr)
FI (1) FI65231C (fr)
FR (1) FR2342956A1 (fr)
GB (1) GB1573191A (fr)
HU (1) HU172137B (fr)
IL (1) IL51574A (fr)
IN (1) IN144243B (fr)
KE (1) KE3340A (fr)
MY (1) MY8500104A (fr)
NL (1) NL7702170A (fr)
NO (1) NO141989C (fr)
PL (1) PL103734B1 (fr)
SE (1) SE440647B (fr)
SU (1) SU648080A3 (fr)
YU (1) YU40813B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004106299A2 (fr) * 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Derives pyrroliques substitues
KR101329112B1 (ko) * 2005-11-08 2013-11-14 랜박시 래보러터리스 리미티드 (3ｒ,5ｒ)-7-〔2-(4-플루오로페닐)-5-이소프로필-3-페닐-4-〔(4-히드록시 메틸 페닐 아미노)카르보닐〕-피롤-1-일〕-3,5-디히드록시 헵탄산 헤미 칼슘염의 제조 방법
WO2008020314A2 (fr) * 2006-03-14 2008-02-21 Ranbaxy Laboratories Limited Formulations de dosage stabilisantes à base de statine
MX2009000439A (es) * 2006-07-14 2009-02-04 Ranbaxy Lab Ltd Formas polimorficas de un inhibidor de hmg-coa reductasa y usos de las mismas.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH569692A5 (fr) 1971-03-17 1975-11-28 Richter Gedeon Vegyeszet
US4067904A (en) * 1975-12-19 1978-01-10 Mead Johnson & Company Alkylsulfonylphenoxypropanolamine derivatives

Also Published As

Publication number Publication date
IN144243B (fr) 1978-04-15
SE7702251L (sv) 1977-09-03
NL7702170A (nl) 1977-09-06
DD128610A5 (de) 1977-11-30
DK143554B (da) 1981-09-07
JPS52122328A (en) 1977-10-14
FI770651A (fr) 1977-09-03
AT348507B (de) 1979-02-26
FI65231B (fi) 1983-12-30
HU172137B (hu) 1978-06-28
IL51574A (en) 1980-01-31
SU648080A3 (ru) 1979-02-15
AU508766B2 (en) 1980-04-03
FI65231C (fi) 1984-04-10
JPS5923299B2 (ja) 1984-06-01
NO141989B (no) 1980-03-03
DE2709109A1 (de) 1977-09-15
BE851938A (fr) 1977-09-01
FR2342956A1 (fr) 1977-09-30
CH627732A5 (de) 1982-01-29
KE3340A (en) 1983-11-25
IL51574A0 (en) 1977-05-31
MY8500104A (en) 1985-12-31
AU2279577A (en) 1978-09-07
US4310549A (en) 1982-01-12
CS190340B2 (en) 1979-05-31
ATA134177A (de) 1978-07-15
FR2342956B1 (fr) 1982-11-26
DE2709109B2 (de) 1980-01-17
NO770688L (no) 1977-09-05
CA1091254A (fr) 1980-12-09
GB1573191A (en) 1980-08-20
DK143554C (da) 1982-03-08
SE440647B (sv) 1985-08-12
YU54977A (en) 1982-10-31
PL103734B1 (pl) 1979-07-31
DK88577A (da) 1977-09-03
NO141989C (no) 1980-06-11
DE2709109C3 (de) 1980-09-18

Similar Documents

Publication Publication Date Title
YU40622B (en) Process for obtaining 2-piperazinyl-6,7-dimethoxy-quinazolne
YU163577A (en) Process for obtaining 6a,10a-transhexahydro-dibenzo-(b,d)-pyrane-9-one
YU19876A (en) Process for obtaining 1,2,3-thiadiazolyl-carbamide
YU39804B (en) Process for obtaining new gona-4,9(10)-dienes
GB1541766A (en) Process for producing 2,4,6-tri-mesitylene
YU166383A (en) Process for obtaining 4-halo-dihydropyrane
YU163377A (en) Process for obtaining new 2-oxy-5-isopropylidene-7-hydroxy-9-substituted 2,6-methano-3,4,5,6-tetrahydro-2h-1-benzoxycines
YU171677A (en) Process for obtaining 5-m-tolyloxyuracyl
YU143177A (en) Process for obtaining sulfinyl-chloride
HU175611B (hu) Sposob poluchenija 3,5,5-trimetil-geksanoil-ferrocena
YU162577A (en) Process for obtaining guaiacol-p-isobutyl-hydrotropate
YU39587B (en) Process for obtaining new 1,2,3-thiadiazole-5-yl-carbamides
YU309577A (en) Process for obtaining octahydro-indolo-(2,3-a)-quinolizine
HU174318B (hu) Sposob poluchenija 2,4-diamino-5-/3',4',5'-trimetoksi-benzil/-pirimidina
YU298677A (en) Process for preparing 3,4-dideoxy-kanamycin b
HU173385B (hu) Sposob poluchenija novykh 5,6-digidro-4h-dibenzo-skobka-de,h-skobka zakryta-kinolinov
YU40813B (en) Process for obtaining 1-tert-butylamino-3-(2,5 dichlorophenoxio-2-propanoe
YU39341B (en) Process for obtaining n-alkylamide-2-oxopyrrolidines
YU214882A (en) Process for obtaining 5,6-dehydropenicillin
CS190348B2 (en) Process for preparing 2,5-dihydroxybenzensulphates
YU12477A (en) Process for obtaining flavium-chloride
CS182053B1 (en) Process for preparing 3,5-dinitro-o-toluamide
YU143277A (en) Process for obtaining 2-dialkoxy-phosphinylimino-1,3-diethane
YU147077A (en) Process for obtaining 2-diethoxy-phosphinylimino-1,3-dithiethane
HU173239B (hu) Sposob poluchenija 9,10-digidroergozine